Bioscience Vaccines, Inc. (BVI) is a life science company focused on improving the efficacy of vaccines. We will accelerate advancements in the development of vaccines used in the prevention and treatment of various infectious diseases with our proprietary Matrix Immune Modulator™ (MIM). Additionally, the technology can be used for the development of biological warfare vaccines. Bioscience Vaccines, Inc.'s novel technology is derived from an abundant, naturally occurring biomaterial referred to as an extracellular matrix. MIM has the potential to be formulated as a companion product with vaccines already approved by the FDA as well as vaccines currently in the development pipeline. MIM is currently available in 3 different formulations (MIM90, MIM150, and MIM250). The base technology has been used in ~2 million patients worldwide for medical device applications with >10 years of safety data. BVI has 22 domestic and international patents pending for vaccine development targeted for human and animals for the prevention and treatment of infectious diseases and cancer based on research performed at the University of Notre Dame.
| Website | http://www.biosciencevaccines.com |
| Revenue | $1.2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2009 |
| Address | 1400 Cumberland Ave. Ste. C, West Lafayette, Indiana 47906, US |
| Phone | +1 765-464-5890 |
| Technologies | |
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Medical Device, Pharmaceutical |
| Keywords | Vaccine Efficacy, Vaccines, Vaccine Development, Vaccine Technology, Vaccine Research, Novel Vaccines, Biopharma, Pharmaceutical Research, Pharmaceutical, Biotechnology, Therapeutics, Drug Development, Immunology, Disease Prevention, Infectious Disease, Prevention, Treatment, Clinical Trials |
| Competitors | Pfizer, Moderna Therapeutics, Johnson & Johnson, AstraZeneca, Sanofi, GSK, Merck & Co., Inc., Novavax, Bristol Myers Squibb, Takeda +31 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Bioscience Vaccines, Inc. employee's phone or email?
Bioscience Vaccines, Inc. Questions
The Bioscience Vaccines, Inc. annual revenue was $1.2 million in 2026.
Bioscience Vaccines, Inc. is based in West Lafayette, Indiana.
The NAICS codes for Bioscience Vaccines, Inc. are [325, 32, 3254].
The SIC codes for Bioscience Vaccines, Inc. are [283, 28].
Related Companies
